Lipid- and polymer-based nanoparticle systems for the delivery of CRISPR/Cas9

被引：34
作者：
Ashok, Bhaargavi [1 ]
Peppas, Nicholas A. [1 ,2 ,3 ,4 ,5 ]
Wechsler, Marissa E. [6 ]
机构：
[1] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA
[2] Univ Texas Austin, Inst Biomat Drug Delivery & Regenerat Med, Austin, TX 78712 USA
[3] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA
[4] Univ Texas Austin, Coll Pharm, Div Mol Pharmaceut & Drug Delivery, Austin, TX 78712 USA
[5] Univ Texas Austin, Dell Med Sch, Dept Surg & Perioperat Care, Austin, TX 78712 USA
[6] Univ Texas San Antonio, Dept Biomed Engn & Chem Engn, San Antonio, TX 78249 USA
来源：
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY | 2021年 / 65卷
基金：
美国国家卫生研究院;
关键词：
Hydrogels; Nanoparticles; CRISPR; Genome editing; IN-VIVO; TARGETED DELIVERY; MESSENGER-RNA; T-CELLS; GENE; CARRIERS; CANCER; VITRO; DNA; CRISPR-CAS9;
D O I：
10.1016/j.jddst.2021.102728
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The discovery of clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) genome editing systems and their applications in human health and medicine has heralded a new era of biotechnology. However, the delivery of CRISPR therapeutics is arguably the most difficult barrier to overcome for translation to in vivo clinical administration. Appropriate delivery methods are required to efficiently and selectively transport all gene editing components to specific target cells and tissues of interest, while minimizing off-target effects. To overcome this challenge, we discuss and critique nanoparticle delivery strategies, focusing on the use of lipid-based and polymeric-based matrices herein.
引用
收藏
页数：13
相关论文
共 108 条
  • [31] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
    Frangoul, H.
    Altshuler, D.
    Cappellini, M. D.
    Chen, Y-S
    Domm, J.
    Eustace, B. K.
    Foell, J.
    de la Fuente, J.
    Grupp, S.
    Handgretinger, R.
    Ho, T. W.
    Kattamis, A.
    Kernytsky, A.
    Lekstrom-Himes, J.
    Li, A. M.
    Locatelli, F.
    Mapara, M. Y.
    de Montalembert, M.
    Rondelli, D.
    Sharma, A.
    Sheth, S.
    Soni, S.
    Steinberg, M. H.
    Wall, D.
    Yen, A.
    Corbacioglu, S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03) : 252 - 260
  • [32] Biodegradable capsules as non-viral vectors for in vitro delivery of PEI/siRNA polyplexes for efficient gene silencing
    Ganas, Carolin
    Weiss, Annika
    Nazarenus, Moritz
    Roesler, Susanne
    Kissel, Thomas
    Gil, Pilar Rivera
    Parak, Wolfgang J.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2014, 196 : 132 - 138
  • [33] Intracellularly Biodegradable Polyelectrolyte/Silica Composite Microcapsules as Carriers for Small Molecules
    Gao, Hui
    Goryacheva, Olga A.
    Tarakina, Nadezda V.
    Sukhorukov, Gleb B.
    [J]. ACS APPLIED MATERIALS & INTERFACES, 2016, 8 (15) : 9651 - 9661
  • [34] Hyperbranched poly(β-amino ester) based polyplex nanopaticles for delivery of CRISPR/Cas9 system and treatment of HPV infection associated cervical cancer
    Gao, Xueqin
    Jin, Zhuang
    Tan, Xiangyu
    Zhang, Chong
    Zou, Chenming
    Zhang, Wei
    Ding, Jiahui
    Das, Bhudev C.
    Severinov, Konstantin
    Hitzeroth, Inga Isabel
    Debata, Priya Ranjan
    He, Dan
    Ma, Xin
    Tian, Xun
    Gao, Qinglei
    Wu, Jun
    Tian, Rui
    Cui, Zifeng
    Fan, Weiwen
    Huang, Zhaoyue
    Cao, Chen
    Bao, Yuxian
    Tan, Songwei
    Hu, Zheng
    [J]. JOURNAL OF CONTROLLED RELEASE, 2020, 321 : 654 - 668
  • [35] Adenoviral vectors - A promising tool for gene therapy
    Ghosh, SS
    Gopinath, P
    Ramesh, A
    [J]. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2006, 133 (01) : 9 - 29
  • [36] Gil P.R., 2010, EUR CELL MAT, V20, P213
  • [37] Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
    Gilbert, Luke A.
    Horlbeck, Max A.
    Adamson, Britt
    Villalta, Jacqueline E.
    Chen, Yuwen
    Whitehead, Evan H.
    Guimaraes, Carla
    Panning, Barbara
    Ploegh, Hidde L.
    Bassik, Michael C.
    Qi, Lei S.
    Kampmann, Martin
    Weissman, Jonathan S.
    [J]. CELL, 2014, 159 (03) : 647 - 661
  • [38] CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
    Gilbert, Luke A.
    Larson, Matthew H.
    Morsut, Leonardo
    Liu, Zairan
    Brar, Gloria A.
    Torres, Sandra E.
    Stern-Ginossar, Noam
    Brandman, Onn
    Whitehead, Evan H.
    Doudna, Jennifer A.
    Lim, Wendell A.
    Weissman, Jonathan S.
    Qi, Lei S.
    [J]. CELL, 2013, 154 (02) : 442 - 451
  • [39] Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics
    Givens, Brittany E.
    Naguib, Youssef W.
    Geary, Sean M.
    Devor, Eric J.
    Salem, Aliasger K.
    [J]. AAPS JOURNAL, 2018, 20 (06):
  • [40] Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics-An innate immune system standpoint
    Granot, Yasmin
    Peer, Dan
    [J]. SEMINARS IN IMMUNOLOGY, 2017, 34 (0C) : 68 - 77
12345678910